Impact of sex and gender on post-COVID-19 syndrome, Switzerland, 2020
BackgroundWomen are overrepresented among individuals with post-acute sequelae of SARS-CoV-2 infection (PASC). Biological (sex) as well as sociocultural (gender) differences between women and men might account for this imbalance, yet their impact on PASC is unknown.AimWe assessed the impact of sex and gender on PASC in a Swiss population.MethodOur multicentre prospective cohort study included 2,856 (46% women, mean age 44.2 ± 16.8 years) outpatients and hospitalised patients with PCR-confirmed SARS-CoV-2 infection.ResultsAmong those who remained outpatients during their first infection, women reported persisting symptoms more often than men (40.5% vs 25.5% of men; p < 0.001). This sex difference was absent in hospitalised patients. In a crude analysis, both female biological sex (RR = 1.59; 95% CI: 1.41-1.79; p < 0.001) and a score summarising gendered sociocultural variables (RR = 1.05; 95% CI: 1.03-1.07; p < 0.001) were significantly associated with PASC. Following multivariable adjustment, biological female sex (RR = 0.96; 95% CI: 0.74-1.25; p = 0.763) was outperformed by feminine gender-related factors such as a higher stress level (RR = 1.04; 95% CI: 1.01-1.06; p = 0.003), lower education (RR = 1.16; 95% CI: 1.03-1.30; p = 0.011), being female and living alone (RR = 1.91; 95% CI: 1.29-2.83; p = 0.001) or being male and earning the highest income in the household (RR = 0.76; 95% CI: 0.60-0.97; p = 0.030).ConclusionSpecific sociocultural parameters that differ in prevalence between women and men, or imply a unique risk for women, are predictors of PASC and may explain, at least in part, the higher incidence of PASC in women. Once patients are hospitalised during acute infection, sex differences in PASC are no longer evident.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
|---|---|
| Enthalten in: |
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin - 29(2024), 2 vom: 12. Jan. |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Gender |
|---|
| Anmerkungen: |
Date Completed 15.01.2024 Date Revised 15.01.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.2807/1560-7917.ES.2024.29.2.2300200 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367046288 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367046288 | ||
| 003 | DE-627 | ||
| 005 | 20240115232040.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240114s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2807/1560-7917.ES.2024.29.2.2300200 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1260.xml |
| 035 | |a (DE-627)NLM367046288 | ||
| 035 | |a (NLM)38214079 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gebhard, Caroline E |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Impact of sex and gender on post-COVID-19 syndrome, Switzerland, 2020 |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.01.2024 | ||
| 500 | |a Date Revised 15.01.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a BackgroundWomen are overrepresented among individuals with post-acute sequelae of SARS-CoV-2 infection (PASC). Biological (sex) as well as sociocultural (gender) differences between women and men might account for this imbalance, yet their impact on PASC is unknown.AimWe assessed the impact of sex and gender on PASC in a Swiss population.MethodOur multicentre prospective cohort study included 2,856 (46% women, mean age 44.2 ± 16.8 years) outpatients and hospitalised patients with PCR-confirmed SARS-CoV-2 infection.ResultsAmong those who remained outpatients during their first infection, women reported persisting symptoms more often than men (40.5% vs 25.5% of men; p < 0.001). This sex difference was absent in hospitalised patients. In a crude analysis, both female biological sex (RR = 1.59; 95% CI: 1.41-1.79; p < 0.001) and a score summarising gendered sociocultural variables (RR = 1.05; 95% CI: 1.03-1.07; p < 0.001) were significantly associated with PASC. Following multivariable adjustment, biological female sex (RR = 0.96; 95% CI: 0.74-1.25; p = 0.763) was outperformed by feminine gender-related factors such as a higher stress level (RR = 1.04; 95% CI: 1.01-1.06; p = 0.003), lower education (RR = 1.16; 95% CI: 1.03-1.30; p = 0.011), being female and living alone (RR = 1.91; 95% CI: 1.29-2.83; p = 0.001) or being male and earning the highest income in the household (RR = 0.76; 95% CI: 0.60-0.97; p = 0.030).ConclusionSpecific sociocultural parameters that differ in prevalence between women and men, or imply a unique risk for women, are predictors of PASC and may explain, at least in part, the higher incidence of PASC in women. Once patients are hospitalised during acute infection, sex differences in PASC are no longer evident | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Gender | |
| 650 | 4 | |a Post-COVID-19, Long-COVID, Long-Haulers | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a Sex | |
| 650 | 4 | |a Women | |
| 700 | 1 | |a Sütsch, Claudia |e verfasserin |4 aut | |
| 700 | 1 | |a Gebert, Pimrapat |e verfasserin |4 aut | |
| 700 | 1 | |a Gysi, Bianca |e verfasserin |4 aut | |
| 700 | 1 | |a Bengs, Susan |e verfasserin |4 aut | |
| 700 | 1 | |a Todorov, Atanas |e verfasserin |4 aut | |
| 700 | 1 | |a Deforth, Manja |e verfasserin |4 aut | |
| 700 | 1 | |a Buehler, Philipp K |e verfasserin |4 aut | |
| 700 | 1 | |a Meisel, Alexander |e verfasserin |4 aut | |
| 700 | 1 | |a Schuepbach, Reto A |e verfasserin |4 aut | |
| 700 | 1 | |a Zinkernagel, Annelies S |e verfasserin |4 aut | |
| 700 | 1 | |a Brugger, Silvio D |e verfasserin |4 aut | |
| 700 | 1 | |a Acevedo, Claudio |e verfasserin |4 aut | |
| 700 | 1 | |a Patriki, Dimitri |e verfasserin |4 aut | |
| 700 | 1 | |a Wiggli, Benedikt |e verfasserin |4 aut | |
| 700 | 1 | |a Beer, Jürg H |e verfasserin |4 aut | |
| 700 | 1 | |a Friedl, Andrée |e verfasserin |4 aut | |
| 700 | 1 | |a Twerenbold, Raphael |e verfasserin |4 aut | |
| 700 | 1 | |a Kuster, Gabriela M |e verfasserin |4 aut | |
| 700 | 1 | |a Pargger, Hans |e verfasserin |4 aut | |
| 700 | 1 | |a Tschudin-Sutter, Sarah |e verfasserin |4 aut | |
| 700 | 1 | |a Schefold, Joerg C |e verfasserin |4 aut | |
| 700 | 1 | |a Spinetti, Thibaud |e verfasserin |4 aut | |
| 700 | 1 | |a Henze, Chiara |e verfasserin |4 aut | |
| 700 | 1 | |a Pasqualini, Mina |e verfasserin |4 aut | |
| 700 | 1 | |a Sager, Dominik F |e verfasserin |4 aut | |
| 700 | 1 | |a Mayrhofer, Lilian |e verfasserin |4 aut | |
| 700 | 1 | |a Grieder, Mirjam |e verfasserin |4 aut | |
| 700 | 1 | |a Tontsch, Janna |e verfasserin |4 aut | |
| 700 | 1 | |a Franzeck, Fabian C |e verfasserin |4 aut | |
| 700 | 1 | |a Wendel Garcia, Pedro D |e verfasserin |4 aut | |
| 700 | 1 | |a Hofmaenner, Daniel A |e verfasserin |4 aut | |
| 700 | 1 | |a Scheier, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Bartussek, Jan |e verfasserin |4 aut | |
| 700 | 1 | |a Haider, Ahmed |e verfasserin |4 aut | |
| 700 | 1 | |a Grämer, Muriel |e verfasserin |4 aut | |
| 700 | 1 | |a Mikail, Nidaa |e verfasserin |4 aut | |
| 700 | 1 | |a Rossi, Alexia |e verfasserin |4 aut | |
| 700 | 1 | |a Zellweger, Núria |e verfasserin |4 aut | |
| 700 | 1 | |a Opić, Petra |e verfasserin |4 aut | |
| 700 | 1 | |a Portmann, Angela |e verfasserin |4 aut | |
| 700 | 1 | |a von Känel, Roland |e verfasserin |4 aut | |
| 700 | 1 | |a Pazhenkottil, Aju P |e verfasserin |4 aut | |
| 700 | 1 | |a Messerli, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Buechel, Ronny R |e verfasserin |4 aut | |
| 700 | 1 | |a Kaufmann, Philipp A |e verfasserin |4 aut | |
| 700 | 1 | |a Treyer, Valerie |e verfasserin |4 aut | |
| 700 | 1 | |a Siegemund, Martin |e verfasserin |4 aut | |
| 700 | 1 | |a Held, Ulrike |e verfasserin |4 aut | |
| 700 | 1 | |a Regitz-Zagrosek, Vera |e verfasserin |4 aut | |
| 700 | 1 | |a Gebhard, Catherine |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin |d 1995 |g 29(2024), 2 vom: 12. Jan. |w (DE-627)NLM115683283 |x 1560-7917 |7 nnns |
| 773 | 1 | 8 | |g volume:29 |g year:2024 |g number:2 |g day:12 |g month:01 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2807/1560-7917.ES.2024.29.2.2300200 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 29 |j 2024 |e 2 |b 12 |c 01 | ||